Valeo Financial Advisors LLC Buys 552 Shares of Colgate-Palmolive (NYSE:CL)

Valeo Financial Advisors LLC grew its stake in shares of Colgate-Palmolive (NYSE:CL) by 5.1% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 11,426 shares of the company’s stock after buying an additional 552 shares during the quarter. Valeo Financial Advisors LLC’s holdings in Colgate-Palmolive were worth $1,029,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Regal Investment Advisors LLC boosted its stake in Colgate-Palmolive by 1.6% in the fourth quarter. Regal Investment Advisors LLC now owns 7,574 shares of the company’s stock valued at $604,000 after acquiring an additional 121 shares in the last quarter. M&G Investment Management Ltd. lifted its stake in shares of Colgate-Palmolive by 0.3% during the fourth quarter. M&G Investment Management Ltd. now owns 49,269 shares of the company’s stock worth $3,942,000 after buying an additional 125 shares during the period. Wealthcare Advisory Partners LLC lifted its stake in shares of Colgate-Palmolive by 3.9% during the fourth quarter. Wealthcare Advisory Partners LLC now owns 3,404 shares of the company’s stock worth $271,000 after buying an additional 127 shares during the period. &PARTNERS lifted its stake in shares of Colgate-Palmolive by 0.7% during the fourth quarter. &PARTNERS now owns 17,643 shares of the company’s stock worth $1,406,000 after buying an additional 129 shares during the period. Finally, AMG National Trust Bank lifted its stake in shares of Colgate-Palmolive by 0.4% during the fourth quarter. AMG National Trust Bank now owns 30,232 shares of the company’s stock worth $2,410,000 after buying an additional 131 shares during the period. 80.41% of the stock is owned by institutional investors.

Colgate-Palmolive Trading Down 0.2 %

CL traded down $0.23 on Wednesday, hitting $95.89. The company had a trading volume of 2,114,198 shares, compared to its average volume of 4,483,127. The company’s fifty day moving average price is $94.17 and its 200 day moving average price is $87.90. Colgate-Palmolive has a 1 year low of $67.62 and a 1 year high of $99.08. The company has a current ratio of 1.06, a quick ratio of 0.70 and a debt-to-equity ratio of 13.21. The firm has a market cap of $78.67 billion, a P/E ratio of 30.42, a PEG ratio of 3.57 and a beta of 0.39.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, April 26th. The company reported $0.86 EPS for the quarter, topping the consensus estimate of $0.82 by $0.04. Colgate-Palmolive had a return on equity of 485.40% and a net margin of 13.22%. The business had revenue of $5.07 billion during the quarter, compared to analyst estimates of $4.96 billion. During the same period last year, the business posted $0.73 earnings per share. The company’s quarterly revenue was up 6.2% on a year-over-year basis. As a group, equities analysts expect that Colgate-Palmolive will post 3.53 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, August 15th. Investors of record on Friday, July 19th will be paid a dividend of $0.50 per share. The ex-dividend date of this dividend is Friday, July 19th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.09%. Colgate-Palmolive’s payout ratio is 63.29%.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on the stock. Morgan Stanley lifted their price objective on shares of Colgate-Palmolive from $101.00 to $103.00 and gave the stock an “overweight” rating in a research note on Tuesday, May 28th. Citigroup boosted their target price on shares of Colgate-Palmolive from $95.00 to $100.00 and gave the company a “buy” rating in a research report on Tuesday, April 16th. Barclays boosted their target price on shares of Colgate-Palmolive from $84.00 to $85.00 and gave the company an “equal weight” rating in a research report on Tuesday, April 30th. BNP Paribas assumed coverage on shares of Colgate-Palmolive in a research report on Monday, June 24th. They set an “outperform” rating and a $109.00 target price for the company. Finally, Bank of America boosted their target price on shares of Colgate-Palmolive from $90.00 to $100.00 and gave the company a “buy” rating in a research report on Monday, April 29th. Three research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat, Colgate-Palmolive presently has an average rating of “Moderate Buy” and an average target price of $93.83.

Insider Activity at Colgate-Palmolive

In other Colgate-Palmolive news, insider John W. Kooyman sold 3,497 shares of the firm’s stock in a transaction on Tuesday, May 7th. The stock was sold at an average price of $93.47, for a total value of $326,864.59. Following the sale, the insider now directly owns 3,181 shares in the company, valued at $297,328.07. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. In related news, insider Sally Massey sold 12,226 shares of the firm’s stock in a transaction that occurred on Thursday, May 9th. The stock was sold at an average price of $94.06, for a total transaction of $1,149,977.56. Following the transaction, the insider now owns 13,924 shares in the company, valued at approximately $1,309,691.44. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider John W. Kooyman sold 3,497 shares of the business’s stock in a transaction that occurred on Tuesday, May 7th. The shares were sold at an average price of $93.47, for a total value of $326,864.59. Following the completion of the sale, the insider now owns 3,181 shares of the company’s stock, valued at approximately $297,328.07. The disclosure for this sale can be found here. 0.37% of the stock is owned by corporate insiders.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.